* participant, in opinion of the investigator, is not likely to survive \>=48 hours beyond day 1 * participant has a diagnosis of asymptomatic covid-19, mild covid-19, or critical covid-19 on day 1 * participant has a documented medical history of infection with hepatitis a, b, c, or with human immunodeficiency virus (with a detectable viral load and cd4 count \<500 cells per micro liter), or a documented active infection with tuberculosis. * the participant has clinically significant electrocardiogram (ecg) abnormalities at screening other protocol defined inclusion/exclusion criteria may apply

* participant, in opinion of the investigator, is not likely to survive \>=48 hours beyond day 1 * participant has a diagnosis of asymptomatic covid-19, mild covid-19, or critical covid-19 on day 1 * participant has a documented medical history of infection with hepatitis a, b, c, or with human immunodeficiency virus (with a detectable viral load and cd4 count \<500 cells per micro liter), or a documented active infection with tuberculosis. * the participant has clinically significant electrocardiogram (ecg) abnormalities at screening other protocol defined inclusion/exclusion criteria may apply

- participant, in opinion of the investigator, is not likely to survive >=48 hours beyond day 1 - participant has a diagnosis of asymptomatic covid-19, mild covid-19, or critical covid-19 on day 1 - participant has a documented medical history of infection with hepatitis a, b, c, or with human immunodeficiency virus (with a detectable viral load and cd4 count <500 cells per micro liter), or a documented active infection with tuberculosis. - the participant has clinically significant electrocardiogram (ecg) abnormalities at screening other protocol defined inclusion/exclusion criteria may apply

- participant, in opinion of the investigator, is not likely to survive >=48 hours beyond day 1 - participant has a diagnosis of asymptomatic covid-19, mild covid-19, or critical covid-19 on day 1 - participant has a documented medical history of infection with hepatitis a, b, c, or with human immunodeficiency virus (with a detectable viral load and cd4 count <500 cells per micro liter), or a documented active infection with tuberculosis. - the participant has clinically significant electrocardiogram (ecg) abnormalities at screening other protocol defined inclusion/exclusion criteria may apply